Home › Funds › GREAT POINT PARTNERS LLC › CLYM
GREAT POINT PARTNERS LLC position in CLYM
CLIMB BIO INC · Health Care
GREAT POINT PARTNERS LLC reported holding 1,000,000 shares of CLYM (CLIMB BIO INC) in its Q2 2026 13F filing — a position valued at US$13.0M, representing 2.74% of its reported portfolio and ranking #16 among its reported holdings. GREAT POINT PARTNERS LLC has disclosed CLYM holdings in 4 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How GREAT POINT PARTNERS LLC's CLYM position evolved
GREAT POINT PARTNERS LLC first disclosed a stake in CLYM in Q3 2024 at 248,168 shares (US$1.3M). The position peaked in Q2 2026 at 1,000,000 shares, worth US$13.0M. Across 4 filings, GREAT POINT PARTNERS LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,000,000 shares valued at US$13.0M — a reduction of -334,130 shares quarter over quarter.. Notable position changes include a 36% increase in Q1 2026 (shares rose 90% over the following quarter), a 25% trim in Q2 2026 (shares fell 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 248.17K | $1.26M | New |
| Q4 2025 | 979.53K | $3.92M | New |
| Q1 2026 | 1.33M | $9.14M | Add |
| Q2 2026 | 1.00M | $13.04M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CLYM and 13F data
CLYM (CLIMB BIO INC) is a Health Care company. 75 other funds we track also report a position in CLYM — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$147.4M), BRAIDWELL LP (US$36.5M), Cormorant Asset Management, LP (US$27.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CLYM
- RA CAPITAL MANAGEMENT, L.P. 11.30M sh · $147.36M · Q2 2026
- BRAIDWELL LP 2.80M sh · $36.48M · Q2 2026
- Cormorant Asset Management, LP 2.11M sh · $27.46M · Q2 2026
- Redmile Group, LLC 1.23M sh · $15.99M · Q2 2026
- Affinity Asset Advisors, LLC 972.00K sh · $12.67M · Q2 2026
- ADAR1 Capital Management, LLC 822.65K sh · $10.73M · Q2 2026
- STEMPOINT CAPITAL LP 742.75K sh · $9.69M · Q2 2026
- Parkman Healthcare Partners LLC 563.48K sh · $7.35M · Q2 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 521.08K sh · $6.79M · Q2 2026
- SPHERA FUNDS MANAGEMENT LTD. 483.75K sh · $6.31M · Q2 2026
- NAN FUNG TRINITY (HK) Ltd 360.65K sh · $4.70M · Q2 2026
- Ally Bridge Group (NY) LLC 249.17K sh · $3.25M · Q2 2026
More on GREAT POINT PARTNERS LLC
FAQ
How long has GREAT POINT PARTNERS LLC held CLYM?
GREAT POINT PARTNERS LLC has disclosed CLYM holdings in 4 of the last 8 reported quarters, going back to Q3 2024.
What is GREAT POINT PARTNERS LLC's current position in CLYM?
As of Q2 2026, GREAT POINT PARTNERS LLC holds 1.00M shares of CLYM (CLIMB BIO INC), valued at $13.04M, representing 2.74% of its reported portfolio and ranking #16.
Has GREAT POINT PARTNERS LLC been buying or selling CLYM?
In the latest 13F filing (Q2 2026), GREAT POINT PARTNERS LLC reduced its position in CLYM. The position peaked in Q2 2026 at 1.00M shares.
Which other funds hold CLYM?
Other major institutional holders of CLYM include RA CAPITAL MANAGEMENT, L.P., BRAIDWELL LP, Cormorant Asset Management, LP, among 75 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.